This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Kerry Grace Morrissey
Vice President
Overview
Kerry Grace Morrissey is a Vice President for Public Health. She oversees a portfolio of domestic and international research studies of disease prevention and health promotion as well as the assessment of biological, behavioral, and environmental risk factors associated with disease, often related to cancer.
Morrissey is an expert in conducting multisite clinic- and community-based epidemiologic research and health program evaluation related to infectious and chronic disease. These projects frequently study women and disadvantaged and rural populations. She directs studies employing a range of observational and experimental designs and applies mixed-methods and innovative data collection techniques, including biological sampling, personal wearable device data, electronic records, geospatial data, and administrative databases to advance data science techniques and the impact of analyses.
Morrissey has led projects with CDC, NCI, and HRSA.
Education
- MPH, Behavioral Sciences, University of California, Berkeley
- BA (cum laude), Sociology/Anthropology (Spanish minor), Denison University
-
Perspective
National Health Center Week: August 6-12, 2023July 2023
As children across the country are getting ready to go back to school, the National Association of Community Health Centers is promoting National Health Center…
-
Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness
Clinical Infectious Diseases
January 2023
A.F. Dalton, Z.A. Weber, K.S. Allen, E. Stenehjem, S.A. Irving, T.L. Spark, K. Adams, et al.
DOILink for: Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness -
Risk of cancer in heterozygous relatives of patients with Fanconi anemia
24,
Genetics in Medicine
January 2022
L.J. McReynolds, N. Giri, L. Leathwood, M.O. Risch, A.G. Carr, B.P. Alter
DOILink for: Risk of cancer in heterozygous relatives of patients with Fanconi anemia